Cefixime EP Impurity C

Product Description
CAT No.
ALN-C081004
CAS No.
108691-83-4
Mol. F.
C16H15N5O7S2
Mol. Wt.
453.4
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : (6R,7S)-7-[[(Z)-2-(2-Aminothiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (as per EP)
Smiles : NC1=NC(/C(C(N[C@@]2([H])C(N(C(C(O)=O)=C(C=C)CS3)[C@@]23[H])=O)=O)=N/OCC(O)=O)=CS1
Inchi : InChI=1S/C16H17N5O8S2/c1-5-6-3-30-13(20-9(6)15(27)29-5)11(14(25)26)19-12(24)10(21-28-2-8(22)23)7-4-31-16(17)18-7/h4-5,11,13,20H,2-3H2,1H3,(H2,17,18)(H,19,24)(H,22,23)(H,25,26)/b21-10-/t5?,11?,13-/m1/s1
Synonym : cefixime 7-epimer
Technical Data
Reference
Analytical method development and validation of cefixime and azithromycin by using RP-HPLC
By Sireesha, E.; Reddy, L. Ramachandra; Dhachinamoorthi, D.nFrom World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(9), 1160-1177
Stability indicating hplc method for the quantification of cefixime, ornidazole and moxifloxacin in solid dosage forms
By Palacharla, Suresh Kumar; Mohan, G. V. Krishna – From Rasayan Journal of Chemistry (2018), 11(4), 1696-1714
Validated stability-indicating HPTLC method for cefixime and azithromycin with preparative isolation, identification, and characterization of degradation products
By Gawande, V. T.; Bothara, K. G.; Satija, C. O. – From Acta Chromatographica (2018), 30(4), 212-218
RFQ